Omnicell (OMCL) said Wednesday that it has opened its innovation lab in Austin, Texas, aimed at rapidly developing new technologies to solve challenges in the healthcare industry.
The technologies will focus on the medication and supply use process, and will range from simple mechanical design to potentially advanced robotics, AI, autonomous devices, sensor technologies, and machine vision, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.